HOME >> BIOLOGY >> NEWS
AGI receives grant to develop environmental science textbook

ALEXANDRIA, VA -- The National Science Foundation (NSF) has awarded the American Geological Institute (AGI) a grant of $998,000 to develop an environmental science textbook for high-school students over the next three years. The new textbook, Environmental Science: Understanding our Changing Earth, will be written in collaboration with scientists from the U.S. Geological Survey (USGS) and the Biological Sciences Curriculum Study (BSCS) and high-school teachers, and will focus on the relationship between humans and their geological surroundings. "Using an Earth system science approach, this innovative, interdisciplinary environmental science curriculum will help students gain the fundamental scientific knowledge and skills that will empower them to be literate citizens of Planet Earth," says Michael Smith, AGI Director of Education and Outreach.

Recent studies show that the demand for environmental science courses is growing and there is a tremendous need for appropriate curriculum materials. The majority of environmental science textbooks emphasize ecology. What makes the AGI project unique is its geoscience approach to environmental problems. The textbook will integrate technology, field, and laboratory-based activities to address five core concepts associated with the environment: human population growth and its impact; sustainability of population with available natural resources; understanding Earth's systems and the effects of natural and induced change; earth processes and risk to life and property; and scientific inquiry in reaching decisions and formulating policy. Accompanying the textbook will be a DVD developed by the USGS having a wide variety of datasets, including a global base map, population, land cover, petroleum deposits, and ecosystems, and ArcView Data Publisher software. This powerful feature will enable students to conduct activities which examine how multiple factors influence the environment and will reinforce the core concepts. A co
'"/>

Contact: Michael J. Smith
msmith@agiweb.org
703-379-2480
American Geological Institute
20-Jun-2003


Page: 1 2 3

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Research on carbohydrate metabolism receives historical recognition
5. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
6. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
7. NJIT professor receives Presidential Award for breakthrough research with adult stem cells
8. University of Pittsburgh receives $10 million grant for head and neck cancer
9. LSU Vet School receives $9.9 million for infectious disease research
10. UCSB professor and director receives two national awards
11. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: AGI receives grant develop environmental science textbook

(Date:5/20/2013)... 2013) - A novel vaccine study from ... research that will be unveiled at the American Association ... meeting takes place Monday, May 20 - Wednesday, May ... , "The main goal of a vaccine is ... pathogen that causes the disease", explained Dr. Hemachand Tummala, ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: